Preparing for Elsa: What Sponsors, Sites, and CROs Need to Know About the FDA’s New AI Era
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
